Alaunos Therapeutics (TCRT) Capital Expenditures Growth (3y) (2012 - 2025)
Alaunos Therapeutics (TCRT) Capital Expenditures Growth (3y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-79.50% |
| Sep 30, 2023 |
-94.15% |
| Jun 30, 2023 |
-35.92% |
| Mar 31, 2023 |
-50.83% |
| Dec 31, 2022 |
5.07% |
| Sep 30, 2022 |
-49.23% |
| Jun 30, 2022 |
-5.25% |
| Mar 31, 2022 |
42.60% |
| Dec 31, 2021 |
83.46% |
| Sep 30, 2021 |
29.85% |
| Jun 30, 2021 |
103.76% |
| Mar 31, 2021 |
65.67% |
| Dec 31, 2020 |
138.96% |
| Sep 30, 2020 |
303.32% |
| Jun 30, 2020 |
166.84% |
| Mar 31, 2020 |
12.74% |
| Dec 31, 2019 |
6.84% |
| Sep 30, 2019 |
-20.38% |
| Jun 30, 2019 |
-12.50% |
| Mar 31, 2019 |
-60.06% |
